Quantitative imaging workshop XIX: Utilizing quantitative thoracic imaging to optimize population health final...

Area of Science:

• Pulmonary and cardiovascular imaging.
• Public health and preventative medicine.

Background:

• Lung cancer screening uses thoracic CT scans to detect and manage lung nodules.
• Eligibility criteria (age >50, >20 pack-year smoking history) identify individuals at high risk for multiple thoracic diseases.
• Thoracic CT scans frequently reveal pulmonary emphysema and coronary artery calcification alongside lung nodules.

Purpose of the Study:

• To review the implications of screen-detected pulmonary emphysema and coronary artery calcification in lung cancer screening.
• To broaden the scope of lung cancer screening towards a comprehensive health evaluation.
• To discuss the role of quantitative imaging in managing these co-occurring thoracic diseases.

Main Methods:

• Multidisciplinary workshop focused on quantitative imaging in lung cancer screening.
• Review of current evidence and emerging issues related to screen-detected non-lung cancer findings.
• Discussion on guiding the evolution of lung cancer screening protocols.

Main Results:

• Lung cancer screening identifies significant rates of pulmonary emphysema and coronary artery calcification in the target population.
• These findings represent major causes of premature death and warrant consideration in screening protocols.
• Quantitative imaging plays a crucial role in assessing the severity and implications of these incidental findings.

Conclusions:

• Lung cancer screening offers a unique opportunity for early detection of multiple life-threatening thoracic diseases.
• Integrating the evaluation of lung parenchyma and coronary arteries enhances the public health impact of screening.
• Further research and standardized protocols for quantitative imaging are needed to optimize comprehensive thoracic disease screening.